This document consists of 15
                                      pages, of which this page
                                      is number 1.



FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
-------------------------------

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
	SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended December 31, 1997

OR

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
	SECURITIES EXCHANGE ACT OF 1934 

	Commission File Number 0-11250 

                  DIONEX CORPORATION				
     (Exact name of registrant as specified in its charter)    

           Delaware                             	94-2647429
(State or other jurisdiction of               (I.R.S. Employer
 incorporation or organization)              Identification No.)  

1228 Titan Way, Sunnyvale, California  		       94086		   
(Address of principal executive offices)	    (Zip Code)

Registrant's telephone number, including area code (408) 737-0700

                                 NONE						                        
(Former name, former address and former fiscal year, if changed
since last report.)

Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange 
Act of 1934 during the preceding 12 months (or for such shorter period 
that the registrant was required to file such reports), and (2) has been 
subject to such filing requirements for the past 90 days.

                                        YES   X    NO_____

Indicate the number of shares outstanding of each of the issuer's classes 
of common stock, as of February 9, 1998:

	        CLASS                    NUMBER OF SHARES

     Common Stock                    11,406,208

<PAGE>
	     	  

DIONEX CORPORATION
INDEX


				PART I.  FINANCIAL INFORMATION


ITEM 1.  FINANCIAL STATEMENTS                      		           Page 


	      CONDENSED CONSOLIDATED BALANCE SHEETS
	      December 31, 1997 and June 30, 1997...................      3

	      CONDENSED CONSOLIDATED STATEMENTS OF INCOME
	      Three Months Ended December 31, 1997 and 1996.........      4

	      CONDENSED CONSOLIDATED STATEMENTS OF INCOME
	      Six Months Ended December 31, 1997 and 1996...........      5

	      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
	      Six Months Ended December 31, 1997 and 1996...........     6-7

	      NOTES TO CONDENSED CONSOLIDATED FINANCIAL
	      STATEMENTS............................................     8-9


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
         CONDITION AND RESULTS OF OPERATIONS.................    10-13


				PART II.  OTHER INFORMATION


ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.      14

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K....................      14

SIGNATURES...................................................      15

















<PAGE>


DIONEX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
-------------

                                                    December 31,   June 30,
         ASSETS                                         1997	        1997
	     
                                                    (unaudited)
Current assets:                                       
  Cash and equivalents (including invested cash
    of $14,204 at December 31, 1997 and $16,586
    at June 30, 1997)............................    $ 21,741     $ 24,624
  Temporary cash investments.....................       6,902        8,252
  Accounts receivable (net of allowance for
    doubtful accounts of $502 at December 31,
    1997 and $533 at June 30, 1997)..............      29,613       29,226
  Inventories....................................       9,396        9,479
  Deferred tax benefits..........................       7,607        7,136
  Prepaid expenses and other.....................       1,406        1,076
         Total current assets....................      76,665       79,793

Property, plant and equipment, net...............      29,688       30,225
Other assets ....................................       9,462        8,145
                                                     $115,815     $118,163

	LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
  Accounts payable...............................    $  3,077     $  4,442
  Accrued liabilities............................      18,237       18,639
  Income taxes payable...........................       6,587        4,905
  Accrued product warranty.......................       3,783        3,592
         Total current liabilities...............      31,684       31,578

Deferred taxes...................................       2,995        2,422
Stockholders' equity:
  Preferred stock (par value $.001 per share;
    1,000,000 shares authorized; none
    outstanding).................................          -	           -
  Common stock (par value $.001 per share;
    40,000,000 shares authorized; outstanding:
    11,530,111 shares at December 31, 1997 and
    11,847,030 shares at June 30, 1997)..........      36,259       36,323
  Retained earnings..............................      43,674       46,622
  Accumulated translation adjustments............      (1,871)        (996)
  Unrealized gain on securities..................       3,074        2,214  
         Total stockholders' equity..............      81,136       84,163
                                                     $115,815     $118,163




See notes to condensed consolidated financial statements. 


3
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
THREE MONTHS ENDED DECEMBER 31, 1997 AND 1996
(In thousands, except per share amounts)
------------------




                                                        1997     1996	
                                                         (unaudited)

Net sales......................................       $39,420  $36,600
Cost of sales..................................        12,353   11,084

Gross profit...................................        27,067   25,516

Operating expenses:
  Selling, general and administrative..........        12,346   12,284
  Research and product development.............         3,318    3,117

     Total operating expenses..................        15,664   15,401

Operating income...............................        11,403   10,115
 
Interest income................................           392      367
Interest expense...............................           (13)     (27)

Income before taxes on income..................        11,782   10,455
Taxes on income................................         4,006    3,607

Net income.....................................       $ 7,776  $ 6,848


Basic earnings per share.......................       $   .67  $   .57

Diluted earnings per share.....................       $   .63  $   .54


Shares used in computing per share amounts:

    Basic ....................................         11,591   12,073

    Diluted ..................................         12,275   12,698
  







 See notes to condensed consolidated financial statements.               


4
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
SIX MONTHS ENDED DECEMBER 31, 1997 AND 1996
(In thousands, except per share amounts)
------------------




                                                        1997     1996	  
                                                         (unaudited)

Net sales......................................       $73,353  $68,108 
Cost of sales..................................        23,120   20,738 

Gross profit...................................        50,233   47,370 

Operating expenses:
  Selling, general and administrative..........        23,911   23,765
  Research and product development.............         6,425    5,874

     Total operating expenses..................        30,336   29,639

Operating income...............................        19,897   17,731
 
Interest income................................           740      712
Interest expense...............................           (54)     (48)

Income before taxes on income..................        20,583   18,395
Taxes on income................................         6,998    6,346

Net income.....................................       $13,585  $12,049


Basic earnings per share.......................       $  1.17  $   .99

Diluted earnings per share.....................       $  1.10  $   .94


Shares used in computing per share amounts:              

  Basic .......................................        11,639   12,180

  Diluted .....................................        12,323   12,809








 See notes to condensed consolidated financial statements.               


5
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
SIX MONTHS ENDED DECEMBER 31, 1997 AND 1996
(In thousands)
------------------


                                                           1997      1996
                                                             (unaudited)
Cash and equivalents provided by (used for):

Cash flows from operating activities:
Net income............................................	  $13,585    $12,049
Adjustments to reconcile net income to net cash
  provided by operating activities:
  Depreciation and amortization.......................	    1,243      1,247
  Deferred taxes......................................	     (471)      (650)

  Changes in assets and liabilities:
    Accounts receivable...............................	   (1,836)      (899)
    Inventories.......................................	     (256)      (136)
    Prepaid expenses and other assets.................	     (367)       215 
    Accounts payable..................................	   (1,295)      (543)
    Accrued liabilities...............................	     (243)    (1,962)
    Income taxes payable..............................	    1,771      1,750 
    Accrued product warranty..........................	      219        238
Net cash provided by operating activities.............	   12,350     11,309

Cash flows from investing activities:
  Purchase of temporary cash investments..............	   (7,650)   (11,100)
  Proceeds from maturities of temporary
    	cash investments.................................	    9,000     18,399
  Purchase of property, plant and equipment...........	     (794)      (899)
  Other...............................................        13        (75)
Net cash provided by investing activities.............       569      6,325

Cash flows from financing activities:
  Net change in notes payable to banks................	       -        (270)
  Sale of common stock................................	    1,094      1,522
  Repurchase of common stock..........................	  (17,691)   (19,936)
  Other...............................................	        9         -	  
Net cash used for financing activities................	  (16,588)   (18,684)

Effect of exchange rate changes on cash...............	      786        423 

Net decrease in cash and equivalents..................	   (2,883)      (627)
Cash and equivalents, beginning of period.............	   24,624     16,986

Cash and equivalents, end of period...................	  $21,741    $16,359
(continued)






6
<PAGE>
DIONEX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
SIX MONTHS ENDED DECEMBER 31, 1997 AND 1996
(In thousands)
------------------


                                                      1997      1996
                                        		             (unaudited)
(continued)
Supplemental disclosures of cash flow information:
  Income taxes paid.................................	$5,787    $5,208
  Interest paid.....................................	$   55    $   50








































See notes to condensed consolidated financial statements.                

7
<PAGE>

DIONEX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(Unaudited)
------------------



1.  Basis of Presentation

    The condensed consolidated financial statements included
    herein have been prepared by the Company, without audit,
    pursuant to the rules and regulations of the Securities and
    Exchange Commission.  Certain information and footnote
    disclosures normally included in financial statements
    prepared in accordance with generally accepted accounting
    principles have been condensed or omitted pursuant to such
    rules and regulations, although the Company believes the
    disclosures which are made are adequate to make the
    information presented not misleading.  It is suggested that
    these condensed consolidated financial statements be read
    in conjunction with the consolidated financial statements
    and the notes thereto included in the Company's Annual
    Report to Stockholders for the fiscal year ended
    June 30, 1997. 

    The unaudited condensed consolidated financial statements
    included herein reflect all adjustments (which include only
    normal, recurring adjustments) which are, in the opinion of
    management, necessary to state fairly the results for the
    periods presented.  The results for such periods are not
    necessarily indicative of the results to be expected for
    the entire fiscal year ending June 30, 1998.

2.  Inventories

    Inventories consist of (in thousands):
				     									
                                    December 31,	    June 30,
                                        1997           1997	  

  Finished goods                       $3,798     	   $3,720
  Work in process                       2,935          2,584
  Raw materials and subassemblies       2,663          3,175

                                       $9,396     	   $9,479











8
<PAGE>
DIONEX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 
(Unaudited)
------------------



3.   Income Taxes

    	The effective income tax rate for the first half of fiscal
    	1998 was 34.0%, down slightly from the 34.5% reported in the
    	first half of fiscal 1997.  

4.   Net Income Per Share
 
     In February 1997, the Financial Accounting Board issued SFAS
     No. 128, Earnings Per Share.  The Company adopted SFAS No.
     128 in the second quarter of fiscal 1998 and restated earnings
     per share data for prior periods to conform with the current
     presentation.  SFAS No. 128 requires a dual presentation of
     basic and diluted earnings per share(EPS).  

     Basic earnings per share excludes dilution and is computed
     by dividing net income by the weighted average of common
     shares outstanding for the period.  Diluted earnings per
     share reflects the potential dilution from securities and
     other contracts which are exercisable or convertible into
     common stock.  Diluted earnings per share is computed by
     dividing net income by the weighted average number of common
     shares that would have been outstanding during the period
     assuming the issuance of common shares for all dilutive
     potential common shares outstanding.  The difference between
     the number of shares outstanding for basic and diluted
     earnings per share is due to stock options outstanding during
     the period.

5.   Common Stock Repurchases

     During the first half of fiscal 1998, the Company
     repurchased 373,950 shares of its common stock on the open
     market compared with 556,800 shares repurchased in the first
     half of the previous fiscal year.  During all of fiscal
     1997, the Company repurchased 791,739 shares.












9
<PAGE>
DIONEX CORPORATION


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
	    CONDITION AND RESULTS OF OPERATIONS

Results of Operations - Three Months Ended December 31, 1997 and 
1996

Net sales for the three months ended December 31, 1997 were $39.4 
million, an increase of 8% from the $36.6 million reported for 
the same period last year.  The Company experienced solid sales 
growth throughout all three of the Company's major geographic 
regions: North America, Europe and Asia.  Had currency rates been 
the same as in the second quarter of last year, sales growth 
would have been 13%.

Gross margin for the second quarter of fiscal 1998 was 68.7%, 
down 1.0% from the 69.7% reported in the same period last year.  
The reduction in gross margin was due primarily to an unfavorable 
effect of currency fluctuations and higher product costs.  There 
were no significant selling price changes between these periods.

Operating expenses of $15.7 million for the second quarter of 
fiscal 1998 were up $263,000, or 2%, from the $15.4 million 
reported for the second quarter last year.  As a percentage of 
sales, operating expenses in the second quarter were 40% compared 
with 42% for the same period last year.  Selling, general and 
administrative expenses increased $62,000, or 1%, to $12.3 
million in the three months ended December 31, 1997.  The 
increase was due to higher selling costs and the costs related to 
the establishment of our Austrian subsidiary, effective January 
1, 1997, partially offset by the favorable effect of currency 
fluctuations on international selling expenses.

Research and development (R&D) costs of $3.3 million increased 
$201,000, or 6%, compared with the same period last year.  The 
level of R&D spending varies depending on both the breadth of the 
Company's R&D efforts and the stage of specific product 
development.

Interest income of $392,000 for the three months ended December 
31, 1997 was essentially unchanged from the $367,000 reported for 
the second quarter last year.

The effective tax rate for the second quarter of fiscal 1998 was 
34.0% compared with 34.5% for the same period last year.  
Variations in the tax rate reflect changes in the mix of taxable 
income among the various tax jurisdictions in which the Company 
does business.  The effective tax rate for the remainder of 
fiscal 1998 is expected to be consistent with the second quarter 
of fiscal 1998.




10
<PAGE>
Net income in the second quarter of fiscal 1998 was $7.8 million, 
an increase of 14% from the $6.8 million reported in the second 
quarter last year. Basic earnings per share of $.67 increased 
$.10, or 18% compared with $.57 per share last year.  Diluted 
earnings per share increased by $.09 per share, or 17%, to $.63 
compared with $.54 reported for the second quarter last year.  
Basic and diluted earnings per share were favorably affected by 
the Company's stock repurchase program.

Results of Operations - Six months ended December 31, 1997 and 
1996

Net sales for the six months ended December 31, 1997 were $73.4 
million, an increase of 8% over the $68.1 million reported for 
the same period last year.  The increase in sales was 
attributable to solid growth in North America and Asia.  Sales 
growth in Europe improved during the six-month period.  Currency 
fluctuations had an unfavorable effect on sales growth in the 
six-month period.  Had currency rates remained the same as the 
first half of last year, sales growth would have been 13%.

Gross margin in the first half of fiscal 1998 was 68.5% compared 
with 69.6% in the first half last year.  The reduction in gross 
margin was primarily attributable to the unfavorable effect of 
currency fluctuations and higher product costs.  There were no 
significant selling price changes between these periods.

Operating expenses for the first six months of fiscal 1998 were 
$30.3 million, an increase of $697,000, or 2%, compared with the 
$29.6 million reported for the first six months last year.  
Operating expenses as a percentage of sales decreased to 41% in 
the first six months of fiscal 1998 compared with 44% in the same 
period last year.  Selling, general and administrative expenses 
for the first six months of fiscal 1998 were $23.9 million, an 
increase of 1% compared with the $23.8 million reported for the 
same period last year.  The increase was primarily due to higher 
personnel and related costs, higher domestic selling expenses and 
the establishment of our subsidiary in Austria, effective January 
1, 1997, partially offset by the favorable effect of currency 
fluctuations.  

R&D expenses for the six months ended December 31, 1997 were $6.4 
million, an increase of $551,000, or 9%, from the $5.9 million 
reported in the same six-month period last year.  The level of 
R&D spending varies depending on both the breadth of the 
Company's R&D efforts and the stage of specific product 
development.

Interest income for the six months ended December 31, 1997 was 
$740,000, which was essentially unchanged from the $712,000 
reported for the same period last year.





11
<PAGE>
The effective tax rate for the first six months of fiscal 1998 
was 34.0% compared with 34.5% for the same period last year.  
Variations in the tax rate reflect changes in the mix of taxable 
income among the various tax jurisdictions in which the Company 
does business.  The effective tax rate for the remainder of 
fiscal 1998 is expected to be consistent with the first half of 
fiscal 1998.

Net income in the first half of fiscal 1998 was $13.6 million, an 
increase of 13% from the $12.0 million reported in the same 
period last year.  Basic earnings per share of $1.17 increased 
$.18, or 18%, compared with $.99 per share reported for the first 
half of last year.  Diluted earnings per share increased by $.16 
per share, or 17%, to $1.10 compared with $.94 reported for the 
same period last year.  Basic and diluted earnings per share were 
favorably affected by the Company's stock repurchase program.

Liquidity and Capital Resources

The Company's liquidity and capital resources remained strong 
during the first half of fiscal 1998.  At December 31, 1997, the 
Company had cash and cash investments of $28.6 million.  

During the second quarter of fiscal 1998, the Company repurchased 
103,400 shares of its common stock , bringing the total shares 
repurchased for the first six months of fiscal 1998 to 373,950.  
During fiscal 1997, the Company repurchased a total of 791,739 
shares of its common stock.

At December 31, 1997, the Company had not utilized any of the  
$14.3 million available under its committed bank lines of credit.  
The Company believes that its cash flow from operations, its 
existing cash and cash investments and its bank lines of credit 
will be adequate to meet its cash requirements for the remainder 
of the fiscal year.

The impact of inflation on Dionex Corporation's financial 
position and results of operations was not significant during the 
six months ended December 31, 1997.

















12
<PAGE>
Except for historical information contained herein, the above 
discussion contains forward-looking statements within the meaning 
of Section 27A of the Securities Act of 1933, as amended, Section 
21E of the Securities and Exchange Act of 1934, as amended, and 
the Private Securities Litigation Reform Act of 1995, and are 
made under the safe harbor provisions thereof.  Such statements 
are subject to certain risks and uncertainties that could cause 
actual results to differ materially from those discussed here.  
Such risks and uncertainties include: competition from other 
products, foreign currency fluctuations, general economic 
conditions, new product development, including market 
receptiveness, existing product obsolescence, fluctuation in 
worldwide demand for analytical instrumentation, the ability to 
manufacture products on an efficient and timely basis and at a 
reasonable cost and in sufficient volume, the ability to attract 
and retain talented employees and other risks as described in 
more detail in the Company's Form 10-K.  Readers are cautioned 
not to place undue reliance on these forward-looking statements 
which reflect management's analysis only as of the date hereof.  
The Company undertakes no obligation to publicly release the 
results of any revision to these forward-looking statements which 
may be made to reflect events or circumstances after the date 
hereof or to reflect the occurrence of unanticipated events.

































13
<PAGE>
PART II.  OTHER INFORMATION

Item 4.  Submission of Matters to a Vote of Security Holders

     On October 23, 1997, the Company held its annual meeting
     for the following purposes: (1) to elect directors, (2)
     to approve an amendment to the Dionex Corporation Stock
     Option Plan to increase the aggregate number of shares
     of Common Stock authorized for issuance under such plan
     by 400,000 shares, (3) to approve an amendment to the
     1988 Directors Stock Option Plan to extend the term of
     the plan to July 27, 2007 and to make certain
     administrative changes, and (4) to ratify the selection
     of Deloitte & Touche LLP as the Company's independent
     auditors for its fiscal year ending June 30, 1998. A
     description of these matters is contained in the
     Company's Proxy Statement, dated September 12, 1997,
     relating to the 1997 Annual Meeting of Stockholders.

     There were 11,688,311 shares of the Company's common
     stock entitled to vote at the Annual Meeting of
     Stockholders based on the September 8, 1997 record
     date.  The Company solicited proxies pursuant to
     Regulation 14 of the Securities Exchange Act of 1934 and
     there was no solicitation in opposition to management's
     nominees for directors as listed in the proxy statement.
     Each director received a minimum of 10,346,253 votes
     which represented at least 89% of the outstanding common
     shares entitled to vote.

     The shareholders approved the amendment to the Company's
     Stock Option Plan, increasing the aggregate number of
     shares under the plan with 8,149,620 votes for,
     1,988,048 votes against and 232,381 votes abstaining.  
     The shareholders also approved the amendment to the 
     Directors Stock Option Plan, with 9,865,808 votes for,
     258,708 votes against and 245,533 votes abstaining.

     The shareholders voted to ratify the selection of
     Deloitte & Touche LLP as the Company's independent
     auditors for its fiscal year ending June 30, 1998.  

Item 6.  Exhibits and Reports on Form 8-K 

         (a)  The following exhibits are filed with the Company's
              Form 10-Q.

        Exhibit		          Description	

          27       	Financial Data Schedule for the
                    period ended December 31, 1997

         (b)  The Company did not file any reports on Form 8-K
              during the quarter ended December 31, 1997.


14
<PAGE>

SIGNATURES 



PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934,
THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF
BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.


                            DIONEX CORPORATION
                            (Registrant)


Date: February 9, 1998 	   By: /s/ A. Blaine Bowman		      
                                A. Blaine Bowman
                                President, Chief Executive
                                Officer        



                            By: /s/ Michael W. Pope		       
                                Michael W. Pope
                                Vice President, Finance
                                and Administration
                               (Principal Financial and
                                Accounting Officer)





























15